M. Uskoković

Vitamin D and Cancer

J. Hart, L. Adorinic, C. S. Spina, 2010 .

5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells.

H. Koeffler, S. Tomoyasu, M. Uskoković, 1999, Cancer research.

Vitamin D and cancer.

V. Tangpricha, M. Holick, L. Adorinic, 2006, Anticancer research.

Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.

G. Miller, M. Uskoković, T. Hedlund, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines.

H. Koeffler, N. Tsuruoka, M. Uskoković, 1997, Cancer research.

20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.

S. de Vos, D. Heber, H. Koeffler, 1995, Cancer research.

Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.

S. de Vos, H. Koeffler, M. Uskoković, 1995, Leukemia research.

Selective vitamin D receptor modulators and their effects on colorectal tumor growth

M. Holick, H. Maehr, L. Adorini, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.

N. Kamada, H. Koeffler, M. Uskoković, 1998, Blood.